Drug Approval Package

 Ranexa (Ranolazine) Extended-Release
Company:  CV Therapeutics, Inc.
Application No.:  021526
Approval Date: 01/27/2006

• Approval Letter(s) (PDF)

• Approvable Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s) (PDF)

• Chemistry Review(s) (PDF)

• Pharmacology Review(s) (PDF)  

• Statistical Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s) & Correspondence (PDF)  

Date created: April 062006

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.